Vancouver, B.C. – Acuitas Therapeutics today announced a poster presentation at the 2025 Control Release Society (CRS) Annual Meeting and Exposition, highlighting an alternative process by which to manufacture RNA… Read More
SOUTH SAN FRANCISCO, CA, VANCOUVER, BC, BOSTON, MA, and EMERYVILLE, CA, July 14, 2025 – ESSA Pharma Inc. (“ESSA,” or the “Company”) (NASDAQ: EPIX) today announced that it has entered… Read More
Vancouver, BC, Canada – July 14, 2025 – Aspect Biosystems, a biotechnology company pioneering the development of Bioprinted Tissue Therapeutics (BTTs) as a new category in regenerative medicine, today announced… Read More
The projects will advance new knowledge and scientific breakthroughs in AI-powered disease diagnosis and precision medicine, cancer diagnosis, and organ on a chip systems. These grants recognize the creativity and… Read More
Urinary tract infections (UTIs) affect 150 million people a year, with symptoms ranging from discomfort to fever and even confusion. Health care costs can run to US$3.5 billion each year…. Read More
